Preoperative Assessment of Skeletal Muscle Mass and Muscle Quality Using Computed Tomography: Incidence of Sarcopenia in Patients with Intrahepatic Cholangiocarcinoma Selected for Liver Resection.
intrahepatic cholangiocarcinoma
liver resection
liver surgery
preoperative risk factor
sarcopenia
skeletal muscle mass
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
10 Mar 2022
10 Mar 2022
Historique:
received:
22
01
2022
revised:
28
02
2022
accepted:
08
03
2022
entrez:
25
3
2022
pubmed:
26
3
2022
medline:
26
3
2022
Statut:
epublish
Résumé
Background: Sarcopenia is considered a predictor of poor postoperative and long-term results following liver resection for intrahepatic cholangiocarcinoma (ICC). The aim of our study was to assess the incidence of sarcopenia in patients resected for ICC and its relation to preoperative clinical factors. Methods: Patients resected for ICC in our unit, with available preoperative CT scans within one month before operation, were enrolled in the study. Skeletal muscle index (SMI) and skeletal muscle radiodensity (SMD) were assessed for each patient. Results: Thirty patients matched all inclusion criteria. Low SMI values were documented in 15 patients (50.0%), and low SMD values were documented in 10 patients (33.3%). SMI was significantly greater in males (p < 0.001). In patients who were underweight, the incidence of low SMI was significantly higher than that of high SMI (p = 0.031). In patients who were overweight/obese, the incidence of high SMI was significantly higher than that of low SMI (p = 0.003) and the incidence of low SMD was significantly higher than that of high SMD (p = 0.038). In the univariate analysis, no preoperative factors (clinical and tumor-related factors), in particular BMI, were found to be independent predictors of low SMI. Conclusions: The incidence of sarcopenia was 50.0% in patients selected for liver resection for ICC and was not related to the preoperative clinical factors. A multidisciplinary evaluation of the nutritional status is fundamental before liver resection in patients.
Identifiants
pubmed: 35329856
pii: jcm11061530
doi: 10.3390/jcm11061530
pmc: PMC8956038
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Cancer Med. 2021 Jul;10(14):4768-4780
pubmed: 34105304
J Gastrointest Surg. 2013 Dec;17(12):2123-32
pubmed: 24065364
Oncotarget. 2017 Aug 10;8(45):79884-79896
pubmed: 29108370
Front Oncol. 2021 Dec 10;11:769696
pubmed: 34956888
World J Surg. 2019 Sep;43(9):2271-2280
pubmed: 31041559
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Front Oncol. 2021 Nov 19;11:744311
pubmed: 34868941
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2569-78
pubmed: 19755644
Liver Int. 2019 Jul;39(7):1307-1314
pubmed: 31070868
Lancet. 2021 Jan 30;397(10272):428-444
pubmed: 33516341
J Clin Med. 2021 Sep 23;10(19):
pubmed: 34640358
J Nutr. 1997 May;127(5 Suppl):990S-991S
pubmed: 9164280
Appl Physiol Nutr Metab. 2008 Oct;33(5):997-1006
pubmed: 18923576
Cancers (Basel). 2021 Oct 26;13(21):
pubmed: 34771524
J Hepatol. 2020 Feb;72(2):364-377
pubmed: 31954498
Int J Clin Exp Med. 2015 Oct 15;8(10):18245-54
pubmed: 26770426
Am J Surg. 2019 Nov;218(5):952-958
pubmed: 30902342
Ann Surg Oncol. 2017 Apr;24(4):1037-1045
pubmed: 27837297
Dig Surg. 2019;36(2):144-152
pubmed: 29455204
Updates Surg. 2020 Sep;72(3):681-691
pubmed: 32410162